Role of serotonin in the regulation of renal proximal tubular epithelial cells

References

• Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM. Serotonin: A review. J Vet Pharmacol Therapeut. 2008;31:187–199.
   PubMed Web of Science ®Google Scholar
• Papadimas GK, Tzirogiannis KN, Mykoniatis MG, Grypioti AD, Manta GA, Panoutsopoulos GI. The emerging role of serotonin in liver regeneration. Swiss Med Weekly. 2012;142:w13548.
   PubMed Web of Science ®Google Scholar
• Kroll MH, Afshar-Kharghan V. Platelets in pulmonary vascular physiology and pathology. Pulm Circul. 2012;2:291–308.
   PubMedGoogle Scholar
• Verbeke M, Van de Voorde J, de Ridder L, Lameire N. Beneficial effect of serotonin 5-HT2-receptor antagonism on renal blood flow autoregulation in cyclosporin-treated rats. J Am Soc Nephrol. 1999;10:28–34.
   PubMed Web of Science ®Google Scholar
• Friedrich F, Paulmichl M, Kolb HA, Lang F. Inward rectifier K channels in renal epithelioid cells (MDCK) activated by serotonin. J Membr Biol. 1988;106:149–155.
   PubMed Web of Science ®Google Scholar
• Sole MJ, Madapallimattam A, Baines AD. An active pathway for serotonin synthesis by renal proximal tubules. Kidney Int. 1986;29:689–694.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yamaji Y, Kitajima W, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol. 1990;258:F28–F33.
   PubMed Web of Science ®Google Scholar
• Takata K, Matsuzaki T, Tajika Y, Ablimit A, Hasegawa T. Localization and trafficking of aquaporin 2 in the kidney. Histochem Cell Biol. 2008;130:197–209.
   PubMed Web of Science ®Google Scholar
• Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 1994;46:157–203.
   PubMed Web of Science ®Google Scholar
• Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083–1152.
   PubMed Web of Science ®Google Scholar
• Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res. 2008;195:198–213.
   PubMed Web of Science ®Google Scholar
• Raymond JR, Mukhin YV, Gelasco A, et al. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Therapeut. 2001;92:179–212.
   PubMed Web of Science ®Google Scholar
• Shoji T, Tamaki T, Fukui K, Iwao H, Abe Y. Renal hemodynamic responses to 5-hydroxytryptamine (5-HT): Involvement of the 5-HT receptor subtypes in the canine kidney. Eur J Pharmacol. 1989;171:219–228.
   PubMed Web of Science ®Google Scholar
• Morán A, Velasco C, Martín ML, San Román L. Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: Involvement of angiotensin II and the 5-HT2 receptor activation. Eur J Pharmacol. 1997;330:205–211.
   PubMed Web of Science ®Google Scholar
• Tian RX, Kimura S, Kondou N, et al. DOI, a 5-HT2 receptor agonist, induces renal vasodilation via nitric oxide in anesthetized dogs. Eur J Pharmacol. 2002;437:79–84.
   PubMed Web of Science ®Google Scholar
• Calama E, Garcia M, Jarque MJ, Moran A, Martin ML, San Roman L. 5-Hydroxytryptamine-induced vasodilator responses in the hindquarters of the anaesthetized rat, involve beta2-adrenoceptors. J Pharm Pharmacol. 2003;55:1371–1378.
   PubMed Web of Science ®Google Scholar
• Calama E, Moran A, Ortiz de Urbina AV, Martin ML, San Roman L. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Pharmacology. 2004;71:66–72.
   PubMed Web of Science ®Google Scholar
• Lan HY. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens. 2003;12:25–29.
   PubMed Web of Science ®Google Scholar
• Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N. Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol. 2008;19:1681–1691.
   PubMed Web of Science ®Google Scholar
• Liu B, Connolly MK. The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg. 1998;17:3–11.
   PubMed Web of Science ®Google Scholar
• Terryn S, Jouret F, Vandenabeele F, et al. A primary culture of mouse proximal tubular cells, established on collagen-coated membranes. Am J Physiol Renal Physiol. 2007;293:F476–F485.
   PubMed Web of Science ®Google Scholar
• Hara-Chikuma M, Verkman AS. Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule. J Am Soc Nephrol. 2006;17:39–45.
   PubMed Web of Science ®Google Scholar
• Kotlo K, Shukla S, Tawar U, Skidgel RA, Danziger RS. Aminopeptidase N reduces basolateral Na+ -K+ -ATPase in proximal tubule cells. Am J Physiol Renal Physiol. 2007;293:F1047–F1053.
   PubMed Web of Science ®Google Scholar
• Verroust PJ, Christensen EI. Megalin and cubilin–the story of two multipurpose receptors unfolds. Nephrol Dial Transpl. 2002;17:1867–1871.
   PubMed Web of Science ®Google Scholar
• Kamiyama M, Garner MK, Farragut KM, Kobori H. The establishment of a primary culture system of proximal tubule segments using specific markers from normal mouse kidneys. Int J Mol Sci. 2012;13:5098–5111.
   PubMed Web of Science ®Google Scholar
• Yabanoglu S, Akkiki M, Seguelas M-H, Mialet-Perez J, Parini A, Pizzinat N. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol. 2009;46:518–525.
   PubMed Web of Science ®Google Scholar
• Hamasaki Y, Doi K, Maeda-Mamiya R, et al. A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1. Am J Physiol Renal Physiol. 2013;305:F1796–F1803.
   PubMed Web of Science ®Google Scholar
• Tang WW, Ulich TR, Lacey DL, et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol. 1996;148:1169–1180.
   PubMed Web of Science ®Google Scholar
• Meran S, Steadman R. Fibroblasts and myofibroblasts in renal fibrosis. Int J Exp Pathol. 2011;92:158–167.
   PubMed Web of Science ®Google Scholar
• Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 2007;257:143–179.
   PubMed Web of Science ®Google Scholar
• Li B, Wang JH. Fibroblasts and myofibroblasts in wound healing: Force generation and measurement. J Tissue Viabil. 2011;20:108–120.
   PubMed Web of Science ®Google Scholar
• Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003;200:500–503.
   PubMed Web of Science ®Google Scholar
• Yanagita M. Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrol Dial Transpl. 2012;27:3686–3691.
   PubMed Web of Science ®Google Scholar
• Genovese F, Manresa AA, Leeming DJ, Karsdal MA, Boor P. The extracellular matrix in the kidney: A source of novel non-invasive biomarkers of kidney fibrosis? Fibrogen Tissue Rep. 2014;7:4.
   PubMedGoogle Scholar
• LeBleu VS, Teng Y, O’Connell JT, et al. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med. 2013;19:227–231.
   PubMed Web of Science ®Google Scholar
• Catania JM, Chen G, Parrish AR. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol. 2007;292:F905–F911.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Avila G, Iturria C, Vadillo-Ortega F, Ovalle C, Montano M. Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology. 1998;66:196–204.
   PubMed Web of Science ®Google Scholar
• Turck J, Pollock AS, Lee LK, Marti HP, Lovett DH. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem. 1996;271:15074–15083.
   PubMed Web of Science ®Google Scholar
• Zeisberg M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol. 2010;21:1819–1834.
   PubMed Web of Science ®Google Scholar
• Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol. 2003;162:1937–1949.
   PubMed Web of Science ®Google Scholar
• Razzaque MS, Taguchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Elect Microsc. 2002;35:68–80.
   PubMedGoogle Scholar
• Cheng M, Razzaque MS, Nazneen A, Taguchi T. Expression of the heat shock protein 47 in gentamicin-treated rat kidneys. Int J Exp Pathol. 1998;79:125–132.
   PubMed Web of Science ®Google Scholar
• Razzaque MS, Taguchi T. Localization of HSP47 in cisplatin-treated rat kidney: A possible role in tubulointerstitial damage. Clin Exp Nephrol. 1999;3:222–228.
   Google Scholar
• Razzaque MS, Shimokawa I, Nazneen A, Higami Y, Taguchi T. Age-related nephropathy in the Fischer 344 rat is associated with overexpression of collagens and collagen-binding heat shock protein 47. Cell Tissue Res. 1998;293:471–478.
   PubMed Web of Science ®Google Scholar
• Liu D, Razzaque MS, Cheng M, Taguchi T. The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats. Histochem J. 2001;33:621–628.
   PubMedGoogle Scholar
• Yokoi H, Mukoyama M, Nagae T, et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol. 2004;15:1430–1440.
   PubMed Web of Science ®Google Scholar
• Moselhy S. Pathogenesis of primary tubulointerstitial nephritis. Egypt J Pediatr Allergy Immunol. 2008;6:35–37.
   Google Scholar
• Tang WW, Van GY, Qi M. Myofibroblast and [alpha]1(III) collagen expression in experimental tubulointerstitial nephritis. Kidney Int. 1997;51:926–931.
   PubMed Web of Science ®Google Scholar
• Creely JJ, DiMari SJ, Howe AM, Hyde CP, Haralson MA. Effects of epidermal growth factor on collagen synthesis by an epithelioid cell line derived from normal rat kidney. Am J Pathol. 1990;136:1247–1257.
   PubMed Web of Science ®Google Scholar
• Kuncio GS, Neilson EG, Haverty T. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 1991;39:550–556.
   PubMed Web of Science ®Google Scholar
• Hogemann B, Gillessen A, Bocker W, Rauterberg J, Domschke W. Myofibroblast-like cells produce mRNA for type I and III procollagens in chronic active hepatitis. Scand J Gastroenterol. 1993;28:591–594.
   PubMed Web of Science ®Google Scholar
• Diegelmann RF, Evans MC. Wound healing: An overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen J, Yan J, et al. Effect of interleukin 6 deficiency on renal interstitial fibrosis. PLoS One. 2012;7:e52415.
   PubMed Web of Science ®Google Scholar
• Girndt M, Kohler H, Schiedhelm-Weick E, Schlaak JF, Meyer zum Buschenfelde KH, Fleischer B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 1995;47:559–565.
   PubMed Web of Science ®Google Scholar
• Linderholm M, Ahlm C, Settergren B, Waage A, Tarnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis. 1996;173:38–43.
   PubMed Web of Science ®Google Scholar
• Malide D, Russo P, Bendayan M. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Human Pathol. 1995;26:558–564.
   PubMed Web of Science ®Google Scholar